Cargando…

Pathways of Neutrophil Granulocyte Activation in Hereditary Angioedema with C1 Inhibitor Deficiency

Hereditary angioedema (HAE) with C1-inhibitor deficiency belongs to bradykinin-mediated angioedemas. It is characterized by recurrent subcutaneous and/or submucosal swelling episodes (HAE attacks) and erythema marginatum skin rash as a pre-attack (prodromal) phase. HAE attacks were shown to be accom...

Descripción completa

Detalles Bibliográficos
Autores principales: Kajdácsi, Erika, Veszeli, Nóra, Mező, Blanka, Jandrasics, Zsófia, Kőhalmi, Kinga Viktória, Ferrara, Anne Lise, Cervenak, László, Varga, Lilian, Farkas, Henriette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272702/
https://www.ncbi.nlm.nih.gov/pubmed/33606193
http://dx.doi.org/10.1007/s12016-021-08847-4
_version_ 1783721266919768064
author Kajdácsi, Erika
Veszeli, Nóra
Mező, Blanka
Jandrasics, Zsófia
Kőhalmi, Kinga Viktória
Ferrara, Anne Lise
Cervenak, László
Varga, Lilian
Farkas, Henriette
author_facet Kajdácsi, Erika
Veszeli, Nóra
Mező, Blanka
Jandrasics, Zsófia
Kőhalmi, Kinga Viktória
Ferrara, Anne Lise
Cervenak, László
Varga, Lilian
Farkas, Henriette
author_sort Kajdácsi, Erika
collection PubMed
description Hereditary angioedema (HAE) with C1-inhibitor deficiency belongs to bradykinin-mediated angioedemas. It is characterized by recurrent subcutaneous and/or submucosal swelling episodes (HAE attacks) and erythema marginatum skin rash as a pre-attack (prodromal) phase. HAE attacks were shown to be accompanied by peripheral blood neutrophilia. We aimed to find molecular mechanisms that may explain the distinct role of neutrophil granulocytes in HAE. Plasma levels of blood cells and factors related to neutrophil activation (cytokines, chemokines, chemotactic factors, enzymes, and neutrophil extracellular trap) were measured in plasma samples obtained from patients during symptom-free periods (n = 77), during prodromal phase (n = 8) and attacks (n = 14), during a spontaneously resolved attack (n = 1), and in healthy controls (n = 79). Higher counts of white blood cells, lymphocytes, and neutrophil granulocytes were found in symptom-free patients compared with controls; these cell counts were elevated further during HAE attacks. The level of chemokine (C–C motif) ligand 5, monocyte chemoattractant protein-1, and myeloperoxidase were also higher in the symptom-free patients than in the controls. Levels of monocyte chemoattractant protein-1, leukotriene B4, neutrophil elastase, and myeloperoxidase were elevated during attacks. During erythema marginatum, white blood cells and monocyte count and levels of interleukin 8 were elevated compared with symptom-free period. Similar changes were detected during the attack follow-up. We conclude that the activation of NGs in symptom-free periods and a further increase observed during attacks suggests that NGs may be involved in the pathomechanism of HAE with C1-INH deficiency.
format Online
Article
Text
id pubmed-8272702
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-82727022021-07-20 Pathways of Neutrophil Granulocyte Activation in Hereditary Angioedema with C1 Inhibitor Deficiency Kajdácsi, Erika Veszeli, Nóra Mező, Blanka Jandrasics, Zsófia Kőhalmi, Kinga Viktória Ferrara, Anne Lise Cervenak, László Varga, Lilian Farkas, Henriette Clin Rev Allergy Immunol Article Hereditary angioedema (HAE) with C1-inhibitor deficiency belongs to bradykinin-mediated angioedemas. It is characterized by recurrent subcutaneous and/or submucosal swelling episodes (HAE attacks) and erythema marginatum skin rash as a pre-attack (prodromal) phase. HAE attacks were shown to be accompanied by peripheral blood neutrophilia. We aimed to find molecular mechanisms that may explain the distinct role of neutrophil granulocytes in HAE. Plasma levels of blood cells and factors related to neutrophil activation (cytokines, chemokines, chemotactic factors, enzymes, and neutrophil extracellular trap) were measured in plasma samples obtained from patients during symptom-free periods (n = 77), during prodromal phase (n = 8) and attacks (n = 14), during a spontaneously resolved attack (n = 1), and in healthy controls (n = 79). Higher counts of white blood cells, lymphocytes, and neutrophil granulocytes were found in symptom-free patients compared with controls; these cell counts were elevated further during HAE attacks. The level of chemokine (C–C motif) ligand 5, monocyte chemoattractant protein-1, and myeloperoxidase were also higher in the symptom-free patients than in the controls. Levels of monocyte chemoattractant protein-1, leukotriene B4, neutrophil elastase, and myeloperoxidase were elevated during attacks. During erythema marginatum, white blood cells and monocyte count and levels of interleukin 8 were elevated compared with symptom-free period. Similar changes were detected during the attack follow-up. We conclude that the activation of NGs in symptom-free periods and a further increase observed during attacks suggests that NGs may be involved in the pathomechanism of HAE with C1-INH deficiency. Springer US 2021-02-19 2021 /pmc/articles/PMC8272702/ /pubmed/33606193 http://dx.doi.org/10.1007/s12016-021-08847-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Kajdácsi, Erika
Veszeli, Nóra
Mező, Blanka
Jandrasics, Zsófia
Kőhalmi, Kinga Viktória
Ferrara, Anne Lise
Cervenak, László
Varga, Lilian
Farkas, Henriette
Pathways of Neutrophil Granulocyte Activation in Hereditary Angioedema with C1 Inhibitor Deficiency
title Pathways of Neutrophil Granulocyte Activation in Hereditary Angioedema with C1 Inhibitor Deficiency
title_full Pathways of Neutrophil Granulocyte Activation in Hereditary Angioedema with C1 Inhibitor Deficiency
title_fullStr Pathways of Neutrophil Granulocyte Activation in Hereditary Angioedema with C1 Inhibitor Deficiency
title_full_unstemmed Pathways of Neutrophil Granulocyte Activation in Hereditary Angioedema with C1 Inhibitor Deficiency
title_short Pathways of Neutrophil Granulocyte Activation in Hereditary Angioedema with C1 Inhibitor Deficiency
title_sort pathways of neutrophil granulocyte activation in hereditary angioedema with c1 inhibitor deficiency
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272702/
https://www.ncbi.nlm.nih.gov/pubmed/33606193
http://dx.doi.org/10.1007/s12016-021-08847-4
work_keys_str_mv AT kajdacsierika pathwaysofneutrophilgranulocyteactivationinhereditaryangioedemawithc1inhibitordeficiency
AT veszelinora pathwaysofneutrophilgranulocyteactivationinhereditaryangioedemawithc1inhibitordeficiency
AT mezoblanka pathwaysofneutrophilgranulocyteactivationinhereditaryangioedemawithc1inhibitordeficiency
AT jandrasicszsofia pathwaysofneutrophilgranulocyteactivationinhereditaryangioedemawithc1inhibitordeficiency
AT kohalmikingaviktoria pathwaysofneutrophilgranulocyteactivationinhereditaryangioedemawithc1inhibitordeficiency
AT ferraraannelise pathwaysofneutrophilgranulocyteactivationinhereditaryangioedemawithc1inhibitordeficiency
AT cervenaklaszlo pathwaysofneutrophilgranulocyteactivationinhereditaryangioedemawithc1inhibitordeficiency
AT vargalilian pathwaysofneutrophilgranulocyteactivationinhereditaryangioedemawithc1inhibitordeficiency
AT farkashenriette pathwaysofneutrophilgranulocyteactivationinhereditaryangioedemawithc1inhibitordeficiency